196 related articles for article (PubMed ID: 35463337)
1. Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.
Jang HY; Kim IW; Oh JM
Front Oncol; 2022; 12():858855. PubMed ID: 35463337
[TBL] [Abstract][Full Text] [Related]
2. Leukotriene antagonists reduce epileptic seizures-related hospitalization in older adult populations with allergic rhinitis or asthma: A population-based cohort study using the Shizuoka Kokuho database: The Shizuoka study.
Imaichi Y; Nakatani E; Fukutomi Y; Kuriyama N; Mori K; Sugawara A
Epilepsia Open; 2024 Feb; 9(1):200-209. PubMed ID: 37881138
[TBL] [Abstract][Full Text] [Related]
3. Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.
Tsai MJ; Wu PH; Sheu CC; Hsu YL; Chang WA; Hung JY; Yang CJ; Yang YH; Kuo PL; Huang MS
Sci Rep; 2016 Apr; 6():23979. PubMed ID: 27052782
[TBL] [Abstract][Full Text] [Related]
4. Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study.
Tsai ML; Lin HC; Yen CH; Ku JT; Sung SY; Chang H
Children (Basel); 2022 Oct; 9(11):. PubMed ID: 36360335
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene Receptor Antagonists and Risk of Neuropsychiatric Entities: A Meta-Analysis of Observational Studies.
Bai L; Xu Y; Pan T; Zhang Y; Zhou X; Xu J
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):844-854.e9. PubMed ID: 36473625
[TBL] [Abstract][Full Text] [Related]
6. Relationship Between Leukotriene Receptor Antagonists on Cancer Development in Patients With Bronchial Asthma: A Retrospective Analysis.
Maeda-Minami A; Hosokawa M; Ishikura Y; Onoda A; Kawano Y; Negishi K; Shimada S; Ihara T; Sugamata M; Takeda K; Mano Y
Anticancer Res; 2022 Jul; 42(7):3717-3724. PubMed ID: 35790293
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene Receptor Antagonist Use and Dementia Risk in Patients With Asthma: A Retrospective Cohort Study.
Ishikura Y; Maeda-Minami A; Hosokawa M; Onoda A; Kawano Y; Ihara T; Sugamata M; Takeda K; Mano Y
In Vivo; 2021; 35(6):3297-3303. PubMed ID: 34697161
[TBL] [Abstract][Full Text] [Related]
8. Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroids.
Dorais M; Blais L; Chabot I; LeLorier J
J Asthma; 2005 Jun; 42(5):385-93. PubMed ID: 16036414
[TBL] [Abstract][Full Text] [Related]
9. Neuromodulatory Effects of Leukotriene receptor antagonists: A comprehensive review.
Sood R; Anoopkumar-Dukie S; Rudrawar S; Hall S
Eur J Pharmacol; 2024 Jun; ():176755. PubMed ID: 38909933
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis.
Gane J; Buckley R
J Allergy Clin Immunol Pract; 2013 Jan; 1(1):65-74. PubMed ID: 24229824
[TBL] [Abstract][Full Text] [Related]
11. Cough, asthma, and cysteinyl-leukotrienes.
Niimi A
Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of Leukotriene Receptor Antagonists to Low-Dose Inhaled Corticosteroids in the Elderly with Mild Asthma.
Hong SH; Kang HR; Nam JH; Park SK; Kim TB; Lee EK
J Allergy Clin Immunol Pract; 2019; 7(8):2642-2652.e3. PubMed ID: 31108218
[TBL] [Abstract][Full Text] [Related]
13. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma.
Bjermer L; Diamant Z
Monaldi Arch Chest Dis; 2002 Feb; 57(1):76-83. PubMed ID: 12174707
[TBL] [Abstract][Full Text] [Related]
14. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists.
Creticos PS
Drugs; 2003; 63 Suppl 2():1-20. PubMed ID: 14984077
[TBL] [Abstract][Full Text] [Related]
15. Asthma pharmacotherapy: an update on leukotriene treatments.
Trinh HKT; Lee SH; Cao TBT; Park HS
Expert Rev Respir Med; 2019 Dec; 13(12):1169-1178. PubMed ID: 31544544
[No Abstract] [Full Text] [Related]
16. Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series.
Park JS; Cho YJ; Yun JY; Lee HJ; Yu J; Yang HJ; Suh DI;
Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35595323
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysis.
Miligkos M; Bannuru RR; Alkofide H; Kher SR; Schmid CH; Balk EM
Ann Intern Med; 2015 Nov; 163(10):756-67. PubMed ID: 26390230
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial.
Higurashi T; Ashikari K; Tamura S; Saigusa Y; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Kessoku T; Hosono K; Yoneda M; Nakajima A
Cancer Prev Res (Phila); 2022 Oct; 15(10):661-668. PubMed ID: 36083855
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.
Capra V; Ambrosio M; Riccioni G; Rovati GE
Curr Med Chem; 2006; 13(26):3213-26. PubMed ID: 17168708
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of leukotriene receptor antagonists in asthma treatment and analysis of background factors evaluated by a questionnaire survey among physicians].
Fukui Y; Hizawa N; Takahashi D; Maeda Y; Kobayashi M; Nasuhara Y; Nishimura M
Nihon Kokyuki Gakkai Zasshi; 2008 Dec; 46(12):972-80. PubMed ID: 19195196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
